197 related articles for article (PubMed ID: 25940993)
1. Sequence-based typing of HLA-A gene in 930 patients with nasopharyngeal carcinoma in Hunan province, southern China.
Tian W; Zhu FM; Wang WY; Cai JH; Zhang W; Li LX; Liu KL; Jin HK; Wang F
Tissue Antigens; 2015 Jul; 86(1):15-20. PubMed ID: 25940993
[TBL] [Abstract][Full Text] [Related]
2. Multiple low-frequency and rare HLA-B allelic variants are associated with reduced risk in 1,105 nasopharyngeal carcinoma patients in Hunan province, southern China.
Tian W; Zhu F; Cai J; Li L; Jin H; Wang W
Int J Cancer; 2020 Sep; 147(5):1397-1404. PubMed ID: 32212153
[TBL] [Abstract][Full Text] [Related]
3. Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China.
Liu Y; Huang Q; Liu W; Liu Q; Jia W; Chang E; Chen F; Liu Z; Guo X; Mo H; Chen J; Rao D; Ye W; Cao S; Hong M
Int J Cancer; 2012 Jul; 131(2):406-16. PubMed ID: 21866545
[TBL] [Abstract][Full Text] [Related]
4. Chemokine CCL27 is a novel plasma biomarker for identification the nasopharyngeal carcinoma patients from the Epstein-Barr virus capsid antigen-specific IgA seropositive population.
Mao MJ; Xue N; Wang XP; Chi PD; Liu YJ; Huang Q; Dai SQ; Liu WL
BMC Cancer; 2018 Jan; 18(1):9. PubMed ID: 29295705
[TBL] [Abstract][Full Text] [Related]
5. Autoantibody Signatures Combined with Epstein-Barr Virus Capsid Antigen-IgA as a Biomarker Panel for the Detection of Nasopharyngeal Carcinoma.
Peng YH; Xu YW; Huang LS; Zhai TT; Dai LH; Qiu SQ; Yang YS; Chen WZ; Zhang LQ; Li EM; Xu LY
Cancer Prev Res (Phila); 2015 Aug; 8(8):729-36. PubMed ID: 25990085
[TBL] [Abstract][Full Text] [Related]
6. Association between HLA alleles and Epstein-Barr virus Zta-IgA serological status in healthy males from southern China.
Yuan LL; Deng CM; Xue WQ; He YQ; Wang TM; Zhang JB; Yang DW; Zhou T; Wu ZY; Liao Y; Zheng MQ; Li DH; Cao LJ; Jia YJ; Zhang WL; Xiao RW; Luo LT; Tong XT; Wu YX; Huang JW; Jia WH
J Gene Med; 2021 Nov; 23(11):e3375. PubMed ID: 34164868
[TBL] [Abstract][Full Text] [Related]
7. [Association study of chromosome 4 STRs polymorphisms with nasopharyngeal carcinoma].
Guo XC; O'Brien SJ; Winkler C; Scott K; Hutcheson H; David V; Kessing B; Zheng YM; Liao J; Lui Y; Guy de T; Zeng Y
Yi Chuan; 2006 Jul; 28(7):783-90. PubMed ID: 16825163
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a semi-quantitative ELISA for IgA antibody against Epstein-Barr virus capsid antigen in the serological diagnosis of nasopharyngeal carcinoma.
Chen H; Chi P; Wang W; Li L; Luo Y; Fu J; Zhang L; Liu W
Int J Infect Dis; 2014 Aug; 25():110-5. PubMed ID: 24878579
[TBL] [Abstract][Full Text] [Related]
9. Leukocyte immunoglobulin-like receptor A3 gene deletion in five Chinese populations and protective association with nasopharyngeal carcinoma.
Tian W; Li LX; Cheng W; Jin HK; Zhang SS
Int J Immunogenet; 2024 Feb; 51(1):32-38. PubMed ID: 38015196
[TBL] [Abstract][Full Text] [Related]
10. Significance of plasma IgA and IgG antibodies to Epstein-Barr virus early and viral capsid antigens in Thai nasopharyngeal carcinoma.
Tiwawech D; Srivatanakul P; Karaluk A; Ishida T
Asian Pac J Cancer Prev; 2003; 4(2):113-8. PubMed ID: 12875623
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX
Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implication of pretreatment titer of serum immunoglobulin A against Epstein-Barr virus capsid antigen in nasopharyngeal carcinoma patients in Sihui, Guangdong.
Ling W; Cao SM; Huang QH; Li YH; Deng MQ
Ai Zheng; 2009 Jan; 28(1):57-9. PubMed ID: 19448418
[TBL] [Abstract][Full Text] [Related]
13. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
[TBL] [Abstract][Full Text] [Related]
14. NKG2C copy number variations in five distinct populations in mainland China and susceptibility to nasopharyngeal carcinoma (NPC).
Li L; Tian W; Wang W; Liu K; Wang J; Jin H; Cai J; Wang J
Hum Immunol; 2015 Mar; 76(2-3):90-4. PubMed ID: 25636564
[TBL] [Abstract][Full Text] [Related]
15. The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove.
Tang M; Lautenberger JA; Gao X; Sezgin E; Hendrickson SL; Troyer JL; David VA; Guan L; McIntosh CE; Guo X; Zheng Y; Liao J; Deng H; Malasky M; Kessing B; Winkler CA; Carrington M; Dé The G; Zeng Y; O'Brien SJ
PLoS Genet; 2012; 8(11):e1003103. PubMed ID: 23209447
[TBL] [Abstract][Full Text] [Related]
16. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP
Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
[TBL] [Abstract][Full Text] [Related]
17. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.
Fachiroh J; Paramita DK; Hariwiyanto B; Harijadi A; Dahlia HL; Indrasari SR; Kusumo H; Zeng YS; Schouten T; Mubarika S; Middeldorp JM
J Clin Microbiol; 2006 Apr; 44(4):1459-67. PubMed ID: 16597877
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of nonviral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China.
Guo X; Johnson RC; Deng H; Liao J; Guan L; Nelson GW; Tang M; Zheng Y; de The G; O'Brien SJ; Winkler CA; Zeng Y
Int J Cancer; 2009 Jun; 124(12):2942-7. PubMed ID: 19296536
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of incidence of nasopharyngeal carcinoma in populations with different fluctuation modes of immunoglobulin A antibody levels against Epstein-Barr virus capsid antigen].
Chen F; Liu K; Huang QH; Liu ZW; Cao SM
Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Feb; 46(2):125-8. PubMed ID: 22490193
[TBL] [Abstract][Full Text] [Related]
20. Expression of EBV antibody EA-IgA, Rta-IgG and VCA-IgA and SA in serum and the implication of combined assay in nasopharyngeal carcinoma diagnosis.
Xia C; Zhu K; Zheng G
Int J Clin Exp Pathol; 2015; 8(12):16104-10. PubMed ID: 26884888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
